ANALYTICAL SPECIFICITY OF COMMERCIALLY AVAILABLE METHODS FOR SERUM PHENYTOIN DETERMINATION

被引：4
作者：
HAUGHEY, DB
MATZKE, GR
HALSTENSON, CE
KEANE, WF
机构：
[1] HENNEPIN CTY MED CTR, REG KIDNEY DIS PROGRAM, DRUG EVALUAT UNIT, MINNEAPOLIS, MN 55415 USA
[2] UNIV MINNESOTA, COLL PHARM, MINNEAPOLIS, MN 55455 USA
[3] UNIV MINNESOTA, COLL MED, MINNEAPOLIS, MN 55455 USA
来源：
JOURNAL OF ANALYTICAL TOXICOLOGY | 1984年 / 8卷 / 03期
关键词：
D O I：
10.1093/jat/8.3.106
中图分类号：
O65 [分析化学];
学科分类号：
070302 ; 081704 ;
摘要：
引用
收藏
页码：106 / 111
页数：6
相关论文
共 21 条
[1]  
ALDWIN L, 1981, CLIN CHEM, V27, P770
[2]  
BASTIANI RJ, 1973, AM J MED TECHNOL, V39, P211
[3]   SERUM CONCENTRATIONS OF FREE DIPHENYLHYDANTOIN AND THEIR RELATIONSHIP TO CLINICAL INTOXICATION [J].
BOOKER, HE ;
DARCEY, B .
EPILEPSIA, 1973, 14 (02) :177-184
[4]  
FINLEY PR, 1981, CLIN CHEM, V27, P405
[5]   FLUORESCENCE POLARIZATION IMMUNOASSAY FOR THE DETERMINATION OF THERAPEUTIC DRUG LEVELS IN HUMAN-PLASMA [J].
JOLLEY, ME .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1981, 5 (05) :236-240
[6]   SOME CAUSES OF INEFFECTIVENESS OF DIPHENYLHYDANTOIN [J].
KUTT, H ;
HAYNES, J ;
MCDOWELL, F .
ARCHIVES OF NEUROLOGY, 1966, 14 (05) :489-&
[7]   USEFULNESS OF BLOOD-LEVELS OF ANTIEPILEPTIC DRUGS [J].
KUTT, H ;
PENRY, JK .
ARCHIVES OF NEUROLOGY, 1974, 31 (05) :283-288
[8]   DIPHENYLHYDANTOIN METABOLISM IN UREMIA [J].
LETTERI, JM ;
MELLK, H ;
LOUIS, S ;
KUTT, H ;
DURANTE, P ;
GLAZKO, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (12) :648-&
[9]  
LEVY G, 1976, EFFECT DISEASE STATE, P143
[10]  
LUDDEN TM, 1977, CLIN PHARMACOL THER, V21, P287
123